Clearmind Medicine Inc [NASDAQ: CMND] price plunged by -0.77 percent to reach at -$0.01. The company report on March 19, 2024 at 7:55 AM that Breakthrough in Wellness: Clearmind Medicine’s Psychedelic Treatment Granted Divisional Patent Approval in China.
A Novel Approach to Combatting Binge Behaviors with Groundbreaking Psychedelic Therapy.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Guru’s Opinion on Clearmind Medicine Inc [CMND]:
The Average True Range (ATR) for Clearmind Medicine Inc is set at 0.19 The Price to Book ratio for the last quarter was 0.81, with the Price to Cash per share for the same quarter was set at 2.96.
CMND Stock Performance Analysis:
Clearmind Medicine Inc [CMND] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -12.24. With this latest performance, CMND shares dropped by -4.44% in over the last four-week period, additionally sinking by -75.65% over the last 6 months – not to mention a drop of -98.79% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CMND stock in for the last two-week period is set at 40.97, with the RSI for the last a single of trading hit 39.46, and the three-weeks RSI is set at 41.37 for Clearmind Medicine Inc [CMND]. The present Moving Average for the last 50 days of trading for this stock 1.4986, while it was recorded at 1.2840 for the last single week of trading, and 6.8415 for the last 200 days.
Insight into Clearmind Medicine Inc Fundamentals:
Clearmind Medicine Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.96 and a Current Ratio set at 1.96.
Clearmind Medicine Inc [CMND] Institutonal Ownership Details
The top three institutional holders of CMND stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2815%. BLACKROCK INC., holding 1.03 billion shares of the stock with an approximate value of $176.59 billion in CMND stocks shares; and BERKSHIRE HATHAWAY INC, currently with $156.75 billion in CMND stock with ownership which is approximately 5.8325%.
